Payments company Cuscal's float is likely to be overshadowed by HMC Capital’s DigiCo REIT – to list by Christmas.

The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...

The last drilling at Golconda took place in 2023, which unlocked some high grade silver zones with hits including 25.9m at ...

Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

Investors were clearly feeling jittery on Wednesday, with many trimming positions in riskier assets amid a more uncertain ...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Fraser Palamara ...

Koba Resources’ step-out drilling has intersected significant uranium at the Chivas and Berber prospects at its Yarramba ...

Bank stocks, including CBA, have fallen on the ASX today, while gold dips below US$2600 and Nvidia hits record highs.

Category four exploration works have been approved allowing C29 (ASX:C29) to carry out a range of tenement-wide activities at ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

The US election failed to deliver extra Chinese stimulus measures companies had been banking on, affecting copper and iron ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...